Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
about
In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerationsTransport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureusRole of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacinOfloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria.Efflux-mediated resistance to fluoroquinolones in gram-negative bacteriaOvercoming antimicrobial resistance by targeting resistance mechanisms.Evidence for an efflux pump in multidrug-resistant Campylobacter jejuniRole of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem.Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.Broad-host-range gyrase A gene probe.Active efflux mechanisms for antimicrobial resistance.Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureusPenetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples.Effect of magnesium complexation by fluoroquinolones on their antibacterial properties.Quinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Efflux-mediated antimicrobial resistance.Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.Resistance to pefloxacin in Pseudomonas aeruginosa.Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.Detection of cfxA2, cfxA3, and cfxA6 genes in beta-lactamase producing oral anaerobesImpermeability to quinolones in gram-positive and gram-negative bacteria.nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.Role of membrane permeability in determining antibiotic resistance in Pseudomonas aeruginosa.Mechanisms of quinolone resistance.The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.
P2860
Q28369137-0DE2F4DD-4295-469D-BB78-AB2D43CB2D48Q33745800-0D8C49D3-B8E3-4257-B31E-FDF17E0DF378Q33756446-7D34D7E9-8E87-42DF-B840-73BEB8AD627DQ33980505-50CF7F4C-9EAE-4A5E-9273-03F2DD716AC9Q34010692-F7CF4028-BD7B-4B08-9E74-83779D72BB04Q34211132-383BAD9E-E203-45A0-90DA-B14EDF58070EQ35118353-BFD71E89-0509-449B-9102-2FC097008ECEQ35119495-BF5CBB51-1D60-4542-A7EE-92CC684CDE3FQ35248719-F22265A4-BEF8-4438-B858-FD5DCB8FEB45Q35276491-DFC80458-F128-4E6A-854D-C55F3B0D9B3EQ35701032-146EF26F-85F2-4E79-BF0A-475A9376C9BFQ35816058-135D00A7-C239-42AA-AC5C-F930A59E64D4Q35816625-525B24BC-526D-40B4-9CF4-F353CC67D292Q35823176-2BC69715-B62F-4A8D-BFD4-C41AEA2E550DQ35893473-7B559836-B05D-4710-8F29-1532D2E12D87Q36138147-780E6409-13CE-4F4E-A084-E513833C7F1AQ36752823-F3AC3B5D-FA45-48A9-A436-8BB3424AA2F7Q36753117-33A8483D-5F6F-40A4-A9F6-7156003D198FQ36758128-9614CF60-1789-4B3B-A042-C51E5D6AB315Q36813396-B22EC098-89BF-4B94-855C-3EBE816213E5Q37222568-A1042DF6-41BE-4516-828B-E15F1D163EE0Q39779448-653113FA-C399-4BFC-8E6E-022EEF1EE42AQ40085920-7D69D008-3592-45A0-A28D-7F7E2201B1D2Q40403515-DC0D85D3-03DB-466D-9DB9-2DDA97C83D4DQ40633568-88384356-8F45-46D2-A8F7-2DB9AA4F9672Q49988467-5D2EC994-E7F2-48C1-A997-10479A771BEE
P2860
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
@ast
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
@en
type
label
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
@ast
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
@en
prefLabel
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
@ast
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
@en
P2860
P356
P1476
Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.
@en
P2093
Robillard NJ
P2860
P304
P356
10.1128/AAC.33.11.1921
P407
P577
1989-11-01T00:00:00Z